Contact
Please use this form to send email to PR contact of this press release:
Can-Fite Applies for FDA Orphan Drug Designation for Namodenoson in the Treatment of Pancreatic Cancer
TO:
Please use this form to send email to PR contact of this press release:
Can-Fite Applies for FDA Orphan Drug Designation for Namodenoson in the Treatment of Pancreatic Cancer
TO: